SGLT2 inhibitors and kidney dysfunction
McMaster Perspective Extended
Dr Gordon Guyatt discusses the changing landscape of diabetes treatment, reviewing the latest high-quality evidence and offering insight into the effectiveness of SGLT2 inhibitors in patients with kidney dysfunction.